CN106008305B - A kind of synthetic method of five substitutions 2- amino-pyrroles derivatives - Google Patents
A kind of synthetic method of five substitutions 2- amino-pyrroles derivatives Download PDFInfo
- Publication number
- CN106008305B CN106008305B CN201610395018.5A CN201610395018A CN106008305B CN 106008305 B CN106008305 B CN 106008305B CN 201610395018 A CN201610395018 A CN 201610395018A CN 106008305 B CN106008305 B CN 106008305B
- Authority
- CN
- China
- Prior art keywords
- amino
- substituted
- phenyl
- aminopyrrole
- synthesis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- QLSWIGRIBOSFMV-UHFFFAOYSA-N 1h-pyrrol-2-amine Chemical class NC1=CC=CN1 QLSWIGRIBOSFMV-UHFFFAOYSA-N 0.000 title claims abstract description 18
- 238000010189 synthetic method Methods 0.000 title claims description 9
- 238000006467 substitution reaction Methods 0.000 title description 2
- -1 pentasubstituted 2-aminopyrrole Chemical class 0.000 claims abstract description 54
- CUONGYYJJVDODC-UHFFFAOYSA-N malononitrile Chemical compound N#CCC#N CUONGYYJJVDODC-UHFFFAOYSA-N 0.000 claims abstract description 8
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 24
- 239000011734 sodium Substances 0.000 claims description 16
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 15
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 13
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 12
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 12
- 238000001308 synthesis method Methods 0.000 claims description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 11
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 11
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 8
- 239000003513 alkali Substances 0.000 claims description 8
- 239000002585 base Substances 0.000 claims description 8
- 229910052736 halogen Inorganic materials 0.000 claims description 5
- 239000003495 polar organic solvent Substances 0.000 claims description 5
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 claims description 4
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical group [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 4
- 239000001632 sodium acetate Substances 0.000 claims description 4
- 235000017281 sodium acetate Nutrition 0.000 claims description 4
- 150000002367 halogens Chemical class 0.000 claims description 3
- 125000005809 3,4,5-trimethoxyphenyl group Chemical group [H]C1=C(OC([H])([H])[H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1* 0.000 claims description 2
- 125000004207 3-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(OC([H])([H])[H])=C1[H] 0.000 claims description 2
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims description 2
- 229910021293 PO 4 Inorganic materials 0.000 claims description 2
- 229910052794 bromium Inorganic materials 0.000 claims description 2
- 229910052801 chlorine Inorganic materials 0.000 claims description 2
- 229910052740 iodine Inorganic materials 0.000 claims description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 2
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims description 2
- 125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 claims description 2
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 claims description 2
- 125000004800 4-bromophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Br 0.000 claims 1
- 125000005059 halophenyl group Chemical group 0.000 claims 1
- 150000003254 radicals Chemical group 0.000 claims 1
- 238000003756 stirring Methods 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 abstract description 26
- 238000003786 synthesis reaction Methods 0.000 abstract description 25
- 238000006243 chemical reaction Methods 0.000 abstract description 16
- 238000000034 method Methods 0.000 abstract description 14
- 239000003814 drug Substances 0.000 abstract description 9
- 229940079593 drug Drugs 0.000 abstract description 8
- 125000003277 amino group Chemical group 0.000 abstract description 5
- 125000000168 pyrrolyl group Chemical group 0.000 abstract description 5
- 238000006555 catalytic reaction Methods 0.000 abstract description 4
- 150000008365 aromatic ketones Chemical class 0.000 abstract description 3
- 229910001385 heavy metal Inorganic materials 0.000 abstract description 3
- 229930014626 natural product Natural products 0.000 abstract description 3
- 230000002194 synthesizing effect Effects 0.000 abstract description 3
- 239000003242 anti bacterial agent Substances 0.000 abstract description 2
- 229940088710 antibiotic agent Drugs 0.000 abstract description 2
- 150000002391 heterocyclic compounds Chemical class 0.000 abstract description 2
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 229940041181 antineoplastic drug Drugs 0.000 abstract 1
- 238000010276 construction Methods 0.000 abstract 1
- 230000009466 transformation Effects 0.000 abstract 1
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 13
- 238000012512 characterization method Methods 0.000 description 12
- 238000001819 mass spectrum Methods 0.000 description 12
- 238000002844 melting Methods 0.000 description 12
- 230000008018 melting Effects 0.000 description 12
- 230000035484 reaction time Effects 0.000 description 10
- 239000007787 solid Substances 0.000 description 9
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 8
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 239000000047 product Substances 0.000 description 5
- 238000005839 oxidative dehydrogenation reaction Methods 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 description 4
- 235000017550 sodium carbonate Nutrition 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 125000001424 substituent group Chemical group 0.000 description 4
- RSEBUVRVKCANEP-UHFFFAOYSA-N 2-pyrroline Chemical compound C1CC=CN1 RSEBUVRVKCANEP-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 3
- 235000011118 potassium hydroxide Nutrition 0.000 description 3
- ZVJHJDDKYZXRJI-UHFFFAOYSA-N pyrroline Natural products C1CC=NC1 ZVJHJDDKYZXRJI-UHFFFAOYSA-N 0.000 description 3
- 235000011121 sodium hydroxide Nutrition 0.000 description 3
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 3
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Natural products CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 2
- 150000001345 alkine derivatives Chemical class 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 125000004093 cyano group Chemical group *C#N 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 150000002825 nitriles Chemical class 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052763 palladium Inorganic materials 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 150000004944 pyrrolopyrimidines Chemical class 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 238000007363 ring formation reaction Methods 0.000 description 2
- 238000006257 total synthesis reaction Methods 0.000 description 2
- 229910052723 transition metal Inorganic materials 0.000 description 2
- 150000003624 transition metals Chemical class 0.000 description 2
- LEIMLDGFXIOXMT-UHFFFAOYSA-N trimethylsilyl cyanide Chemical compound C[Si](C)(C)C#N LEIMLDGFXIOXMT-UHFFFAOYSA-N 0.000 description 2
- PHIMVUDMARQXAQ-UHFFFAOYSA-N 1h-pyrrole-2,3-diamine Chemical class NC=1C=CNC=1N PHIMVUDMARQXAQ-UHFFFAOYSA-N 0.000 description 1
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 1
- 101100481408 Danio rerio tie2 gene Proteins 0.000 description 1
- 101100481410 Mus musculus Tek gene Proteins 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003471 anti-radiation Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- QARVLSVVCXYDNA-UHFFFAOYSA-N bromobenzene Chemical compound BrC1=CC=CC=C1 QARVLSVVCXYDNA-UHFFFAOYSA-N 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000039 congener Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- XYZMOVWWVXBHDP-UHFFFAOYSA-N cyclohexyl isocyanide Chemical compound [C-]#[N+]C1CCCCC1 XYZMOVWWVXBHDP-UHFFFAOYSA-N 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000000749 insecticidal effect Effects 0.000 description 1
- 238000011877 intramolecular nucleophilic addition Methods 0.000 description 1
- 238000003760 magnetic stirring Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- OJURWUUOVGOHJZ-UHFFFAOYSA-N methyl 2-[(2-acetyloxyphenyl)methyl-[2-[(2-acetyloxyphenyl)methyl-(2-methoxy-2-oxoethyl)amino]ethyl]amino]acetate Chemical compound C=1C=CC=C(OC(C)=O)C=1CN(CC(=O)OC)CCN(CC(=O)OC)CC1=CC=CC=C1OC(C)=O OJURWUUOVGOHJZ-UHFFFAOYSA-N 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 1
- DBDUKXZPNKUGAA-UHFFFAOYSA-N n-(2-acetylphenyl)benzenesulfonamide Chemical compound CC(=O)C1=CC=CC=C1NS(=O)(=O)C1=CC=CC=C1 DBDUKXZPNKUGAA-UHFFFAOYSA-N 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 229910000510 noble metal Inorganic materials 0.000 description 1
- 238000005935 nucleophilic addition reaction Methods 0.000 description 1
- 238000010534 nucleophilic substitution reaction Methods 0.000 description 1
- 238000005580 one pot reaction Methods 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 125000004585 polycyclic heterocycle group Chemical group 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 235000015320 potassium carbonate Nutrition 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 150000005255 pyrrolopyridines Chemical class 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 150000003608 titanium Chemical class 0.000 description 1
- 229910000404 tripotassium phosphate Inorganic materials 0.000 description 1
- 235000019798 tripotassium phosphate Nutrition 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
- C07D207/48—Sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pyrrole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
本发明公开一种五取代2‑氨基吡咯衍生物的合成方法,该方法是在极性较大的有机介质中,将邻位氨基卤的芳酮与丙二腈在碱的作用下一步反应,即可得到五取代2‑氨基吡咯衍生物。与传统方法相比,本发明采用价格低廉的普通碱作为促进剂,有效降低了成本,且合成步骤简单,反应收率高,特别是在构建具有吡咯环的药物中,应用这种方法可避免用重金属催化而导致药物中重金属残余量超标的问题。另外,不论邻位氨基卤的芳酮为α‑氨基‑β‑卤芳酮或α‑卤‑β‑氨基芳酮,所合成的产物中氨基均处在吡咯环的2‑位,具有高度的区域选择性。本发明合成的五取代2‑氨基吡咯衍生物可用于稠杂环化合物、天然抗生素、抗癌药物的合成及天然产物结构改造研究领域。The invention discloses a method for synthesizing pentasubstituted 2-aminopyrrole derivatives. The method is to react the aryl ketone of the ortho-amino halide with malononitrile under the action of a base in a highly polar organic medium. The five-substituted 2-aminopyrrole derivative can be obtained. Compared with traditional methods, the present invention uses cheap common bases as accelerators, which effectively reduces costs, and the synthesis steps are simple and the reaction yield is high. Especially in the construction of drugs with pyrrole rings, the application of this method can avoid The use of heavy metal catalysis leads to the problem that the residual amount of heavy metal in the drug exceeds the standard. In addition, regardless of whether the aromatic ketone of the ortho-amino halide is α-amino-β-haloaryl ketone or α-halogen-β-aminoaryl ketone, the amino group in the synthesized product is at the 2-position of the pyrrole ring, which has a high degree of Regional selectivity. The five-substituted 2-aminopyrrole derivative synthesized by the invention can be used in the research field of synthesis of condensed heterocyclic compounds, natural antibiotics, anticancer drugs and structural transformation of natural products.
Description
技术领域technical field
本发明属于五取代2-氨基吡咯衍生物的合成技术领域,具体涉及一种邻位氨基卤的芳酮与丙二腈一步反应合成五取代2-氨基吡咯的方法。The invention belongs to the technical field of synthesis of pentasubstituted 2-aminopyrrole derivatives, and in particular relates to a method for synthesizing pentasubstituted 2-aminopyrrole by one-step reaction of aryl ketone with an ortho-amino halide and malononitrile.
背景技术Background technique
吡咯及其衍生物是一类非常重要的五元杂环化合物。吡咯最早发现于19世纪三十年代,从那以后,吡咯及其衍生物所具有的生物活性和药理作用已引起广泛关注。现今,吡咯及其衍生物已广泛的应用于医药、农药、食品、生物、材料科学以及高分子化学领域。由于吡咯及其衍生物的重要性,人们对其合成方法进行了深入研究。2-氨基吡咯结构单元是许多具有强烈生物活性化合物的一部分,已是公认的许多药物分子结构单元。这些药物能表现出抗炎、抗癌、抗病毒、抗真菌、杀虫、抗辐射,并且对MEK、MK2、FAK、KDR、Tie2以及PDE有强烈的抑制作用。另外,2-氨基吡咯是合成嘌呤同系物如吡咯并嘧啶、吡咯并三嗪和吡咯并吡啶的前体。到现在为止,尽管合成吡咯及其衍生物的方法很多,但关于五取代2-氨基吡咯的合成报道却相对较少。已报道的方法有:(1)由炔烃与三甲基氰基硅在过渡金属Pd、Ni、Co等配合物的催化下,回流得到相应的五取代2-氨基吡咯衍生物;(2)分别由N-苯磺酰氨基苯基甲基甲酮、N-杂芳基磺酰氨基苯基甲基甲酮、N-烷基磺酰氨基苯基甲基甲酮等与醛、含氰基的活泼亚甲基化合物三组份在乙醇或乙腈溶剂中回流反应,得到相应的五取代2-氨基吡咯衍生物;(3)用α,β-不饱和的酰亚胺氰化物与腈在AlCl3催化下90℃反应,得到相应的五取代2-氨基吡咯衍生物;(4)炔烃与苯胺在钛配合物催化下,甲苯溶剂中80℃反应,得到2,3-二氨基吡咯衍生物;(5)在甲苯溶剂中,由苄基对甲苯磺酰亚胺、丁炔二甲酸二甲酯、环已基异腈三组份反应得到相应的五取代2-氨基吡咯衍生物。以上方法不同程度存在一些缺点,如有的方法要用过渡金属作催化剂,在药物合成中重金属残余量超标是药物合成中较难解决的问题;有的方法要用到难以得到的反应原料,会增加合成的成本;有的要在较高温度下进行,甚至要在回流温度下进行,对设备的要求增高。Pyrrole and its derivatives are a very important class of five-membered heterocyclic compounds. Pyrrole was first discovered in the 1930s. Since then, the biological activity and pharmacological effects of pyrrole and its derivatives have attracted widespread attention. Today, pyrrole and its derivatives have been widely used in the fields of medicine, pesticide, food, biology, material science and polymer chemistry. Due to the importance of pyrrole and its derivatives, their synthetic methods have been intensively studied. The 2-aminopyrrole structural unit is a part of many compounds with strong biological activity, and has been recognized as the structural unit of many drug molecules. These drugs can exhibit anti-inflammatory, anti-cancer, anti-viral, anti-fungal, insecticidal, anti-radiation, and strong inhibitory effects on MEK, MK2, FAK, KDR, Tie2 and PDE. In addition, 2-aminopyrroles are precursors for the synthesis of purine congeners such as pyrrolopyrimidines, pyrrolopyrimidines, and pyrrolopyridines. So far, although there are many ways to synthesize pyrrole and its derivatives, there are relatively few reports on the synthesis of pentasubstituted 2-aminopyrrole. The reported methods are as follows: (1) under the catalysis of transition metal Pd, Ni, Co and other complexes, the corresponding five-substituted 2-aminopyrrole derivatives are obtained by refluxing alkyne and trimethylcyanosilane; (2) N-benzenesulfonylaminophenyl methyl ketone, N-heteroarylsulfonylamino phenyl methyl ketone, N-alkylsulfonylamino phenyl methyl ketone, etc. and aldehydes, cyano-containing The three components of the active methylene compound are refluxed in ethanol or acetonitrile solvent to obtain the corresponding five-substituted 2-aminopyrrole derivatives; (3) use α, β-unsaturated imide cyanide and nitrile in AlCl 3. Reaction at 90°C under catalysis to obtain the corresponding pentasubstituted 2-aminopyrrole derivatives; (4) Reaction of alkynes and aniline in toluene solvent at 80°C under the catalysis of titanium complexes to obtain 2,3-diaminopyrrole derivatives ; (5) In toluene solvent, the corresponding five-substituted 2-aminopyrrole derivatives were obtained by reacting three components of benzyl-p-toluenesulfonimide, butynedicarboxylic acid dimethyl ester, and cyclohexyl isonitrile. There are some shortcomings in the above methods in varying degrees. If some methods use transition metals as catalysts, excessive heavy metal residues in drug synthesis are difficult problems to solve in drug synthesis; Increase the cost of synthesis; some have to be carried out at higher temperatures, even at reflux temperature, and the requirements for equipment are increased.
发明内容Contents of the invention
本发明所要解决的技术问题在于克服现有五取代2-氨基吡咯衍生物合成中存在的缺点,提供一种在温和条件下,在极性较大的有机介质中,在普通弱碱的促进下,由邻位氨基卤的芳酮与丙二腈一步合成五取代2-氨基吡咯的方法。The technical problem to be solved by the present invention is to overcome the shortcomings existing in the synthesis of the existing five-substituted 2-aminopyrrole derivatives, and to provide a method that can be used under mild conditions, in a polar organic medium, under the promotion of an ordinary weak base , A one-step synthesis of five-substituted 2-aminopyrroles from aryl ketones and malononitriles in the ortho-amino halide.
解决上述技术问题所采用的技术方案是:在极性较大的有机溶剂中,将式I或式II所示的邻位氨基卤的芳酮与丙二腈、碱按摩尔比为1:1~1.5:0.5~2混合均匀,40~60℃搅拌6~24小时,分离纯化产物,得到式III或式IV所示的五取代2-氨基吡咯衍生物;The technical solution adopted to solve the above-mentioned technical problems is: in a relatively polar organic solvent, the aryl ketone of the ortho amino halide shown in formula I or formula II is mixed with malononitrile and alkali in a molar ratio of 1:1 ~1.5:0.5~2 mixed evenly, stirred at 40~60°C for 6~24 hours, separated and purified the product, and obtained the pentasubstituted 2-aminopyrrole derivative represented by formula III or formula IV;
式I~IV中,Ar1和Ar2各自独立的代表苯基、C1~C4烷基取代苯基、C1~C4烷氧基取代苯基、卤素和C1~C4烷氧基取代的苯基、卤代苯基、硝基取代苯基中的任意一种,优选Ar1和Ar2各自独立的代表苯基、4-甲基苯基、4-甲氧基苯基、2-卤-4,5-二甲氧基苯基、3-甲氧基苯基、3,5-二甲氧基苯基、3,4,5-三甲氧基苯基、4-溴苯基、4-氟苯基、4-氯苯基、4-硝基苯基中的任意一种,X代表Cl、Br或I。In formulas I~IV, Ar 1 and Ar 2 independently represent phenyl, C 1 ~C 4 alkyl substituted phenyl, C 1 ~C 4 alkoxy substituted phenyl, halogen and C 1 ~C 4 alkoxy Any one of substituted phenyl, halogenated phenyl, nitro substituted phenyl, preferably Ar 1 and Ar 2 independently represent phenyl, 4-methylphenyl, 4-methoxyphenyl, 2-halo-4,5-dimethoxyphenyl, 3-methoxyphenyl, 3,5-dimethoxyphenyl, 3,4,5-trimethoxyphenyl, 4-bromobenzene Any one of base, 4-fluorophenyl, 4-chlorophenyl, 4-nitrophenyl, X represents Cl, Br or I.
上述的邻位氨基卤的芳酮与丙二腈、碱的摩尔比优选为1:1~1.5:1~1.5。The molar ratio of the aryl ketone, malononitrile, and base of the above-mentioned ortho-amino halide is preferably 1:1˜1.5:1˜1.5.
上述的极性较大的有机溶剂为甲醇、乙醇、丙醇、N,N-二甲基甲酰胺、乙腈、二甲亚砜中的任意一种,优选甲醇。The above-mentioned relatively polar organic solvent is any one of methanol, ethanol, propanol, N,N-dimethylformamide, acetonitrile, and dimethyl sulfoxide, preferably methanol.
上述的碱为乙酸钠、K2CO3、KHCO3、Na2CO3、K3PO4、NaOH、KOH、乙二胺、三乙胺中的任意一种,优选Na2CO3。The above-mentioned base is any one of sodium acetate, K 2 CO 3 , KHCO 3 , Na 2 CO 3 , K 3 PO 4 , NaOH, KOH, ethylenediamine, and triethylamine, preferably Na 2 CO 3 .
本发明五取代2-氨基吡咯衍生物的合成方法中,不论邻位氨基卤的芳酮中芳环上带有何种取代基及取代基在芳环的何种位置,不论邻位氨基卤的芳酮是α-氨基-β-卤型还是α-卤-β-氨基型,其合成的五取代2-氨基吡咯衍生物具有高度的区域选择性,氨基均处在吡咯环的2-位,即合成的吡咯环中具有1,4-偶极的结构特征,这种结构可进一步发生4+1或4+2关环反应,可用于生物碱、天然产物的全合成及结构改造、合成抗生素、抗癌、抗病毒药物等领域,为药物分子合成和天然产物全合成及结构改造提供新的技术。In the synthetic method of the five-substituted 2-aminopyrrole derivatives of the present invention, no matter what substituent is on the aromatic ring of the aromatic ketone of the ortho-position amino halide and what position the substituent is in the aromatic ring, no matter the position of the ortho-amino halide is Whether the aryl ketone is α-amino-β-halogen or α-halogen-β-amino, the five-substituted 2-aminopyrrole derivatives are highly regioselective, and the amino group is at the 2-position of the pyrrole ring. That is, the synthesized pyrrole ring has the structural characteristics of 1,4-dipole, and this structure can further undergo 4+1 or 4+2 ring-closing reactions, which can be used for the total synthesis and structural modification of alkaloids and natural products, and the synthesis of antibiotics , anti-cancer, anti-viral drugs and other fields, providing new technologies for the synthesis of drug molecules and the total synthesis and structural modification of natural products.
发明人通过实验发现,为了使该反应快速、高效,必须在碱的促进下才能实现,不加碱该反应均不能发生,而且碱的种类和用量对反应起着决定性作用。另外,溶剂对该反应也起着重要的控制作用,在水相介质中,丙二腈会发生水解,导致该反应不能发生。因此,该反应必须在有机介质中才能完成。但由于有机溶剂的种类不同,其极性大小有差别,对该反应的控制能力大小也有差异。实验证明,有机溶剂的极性越大,对该反应的控制能力越大。反应温度对产物结构和收率有很大影响,温度偏低(如室温),反应倾向于生成吡咯啉,温度太高,生成物复杂,产物收率下降。The inventor found through experiments that in order to make the reaction fast and efficient, it must be realized under the promotion of alkali, and the reaction cannot occur without adding alkali, and the type and amount of alkali play a decisive role in the reaction. In addition, the solvent also plays an important role in controlling the reaction. In the aqueous medium, malononitrile will be hydrolyzed, so that the reaction cannot occur. Therefore, the reaction must be carried out in an organic medium. However, due to the different types of organic solvents, their polarity is different, and the ability to control the reaction is also different. Experiments have shown that the greater the polarity of the organic solvent, the greater the ability to control the reaction. The reaction temperature has a great influence on the product structure and yield. If the temperature is low (such as room temperature), the reaction tends to generate pyrroline. If the temperature is too high, the product will be complicated and the product yield will decrease.
本发明的优点在于:The advantages of the present invention are:
1、本发明提供了一个在多种溶剂中均能合成五取代2-氨基吡咯衍生物的方法,如甲醇、乙醇、丙醇、N,N-二甲基甲酰胺、乙腈、二甲亚砜等,其中首选的溶剂是甲醇。1. The present invention provides a method for synthesizing pentasubstituted 2-aminopyrrole derivatives in various solvents, such as methanol, ethanol, propanol, N,N-dimethylformamide, acetonitrile, dimethyl sulfoxide etc., where the preferred solvent is methanol.
2、本发明使用了普通的碱如乙酸钠、乙酸钾、碳酸氢钠、碳酸钾、碳酸钠、磷酸钾、氢氧化钠、氢氧化钾、乙二胺、三乙胺等作为促进剂,其中碳酸钠是首选的促进剂。该促进剂稳定易得,价格低廉,与传统的方法相比,避免了价格昂贵的贵金属钯或其它过度金属配合物的使用,不但有效降低了合成成本,而且在药物合成中避免了金属残余量超标的可能。2, the present invention has used common alkali such as sodium acetate, potassium acetate, sodium bicarbonate, potassium carbonate, sodium carbonate, potassium phosphate, sodium hydroxide, potassium hydroxide, ethylenediamine, triethylamine etc. as promotor, wherein Sodium carbonate is the preferred accelerator. The accelerator is stable and easy to obtain, and the price is low. Compared with the traditional method, it avoids the use of expensive noble metal palladium or other excessive metal complexes, not only effectively reduces the synthesis cost, but also avoids the amount of metal residues in the drug synthesis. Possibility of excess.
3、本发明在碱的促进下,邻位氨基卤的芳酮中卤素被丙二腈的取代反应、分子内氨基对氰基的亲核加成反应形成吡咯啉及由空气中的氧对吡咯啉进行的氧化脱氢反应一次完成,高效地合成了五取代的2-氨基吡咯衍生物。在氧化脱氢的过程中,应用空气中的氧进行氧化脱氢,避免了使用传统的氧化剂如DDQ,使合成五取代2-氨基吡咯更为清洁。3. In the present invention, under the promotion of alkali, the substitution reaction of the halogen in the aryl ketone of the ortho amino halide by malononitrile, the nucleophilic addition reaction of the amino group to the cyano group in the molecule to form pyrroline and the formation of pyrroline by oxygen in the air The oxidative dehydrogenation reaction of morpholino was completed at one time, and five-substituted 2-aminopyrrole derivatives were efficiently synthesized. In the process of oxidative dehydrogenation, oxygen in the air is used for oxidative dehydrogenation, which avoids the use of traditional oxidants such as DDQ, and makes the synthesis of pentasubstituted 2-aminopyrroles cleaner.
4、本发明的合成步骤简单,一步完成了三个反应(亲核取代/分子内的亲核加成/氧化脱氢反应),且反应收率高,最高收率可达到91%。4. The synthesis steps of the present invention are simple, and three reactions (nucleophilic substitution/intramolecular nucleophilic addition/oxidative dehydrogenation reaction) are completed in one step, and the reaction yield is high, and the highest yield can reach 91%.
5、本发明的方法具有高度的区域选择性,不论邻位氨基卤的芳酮中芳环上带有给电子取代基还是吸电子取代基,不论邻位氨基卤的芳酮是α-氨基-β-卤型还是α-卤-β-氨基型,所有产物的氨基均处在了吡咯的2-位,这个2-位的氨基与3-位上的缺电子基可组成1,4-偶极的特殊结构,可发生4+1或4+2关环反应,为合成其它复杂的杂多环化合物提供了新的路线。5. The method of the present invention has a high degree of regioselectivity, regardless of whether the aromatic ketone of the ortho-amino halide has an electron-donating substituent or an electron-withdrawing substituent, no matter whether the aryl ketone of the ortho-amino halide is α-amino- β-halogen type or α-halo-β-amino type, the amino group of all products is in the 2-position of pyrrole, and the 2-position amino group and the electron-deficient group at the 3-position can form a 1,4-even The extremely special structure can undergo 4+1 or 4+2 ring-closing reactions, which provides a new route for the synthesis of other complex heteropolycyclic compounds.
具体实施方式Detailed ways
下面结合实施例对本发明进一步详细说明,但本发明的保护范围不限于这些实施例。The present invention will be described in further detail below in conjunction with the examples, but the protection scope of the present invention is not limited to these examples.
实施例1Example 1
以合成结构式如下的1-对甲苯磺酰基-2-氨基-3-氰基-4-苯基-5-苯甲酰基吡咯为例,具体合成方法如下:Taking the synthesis of 1-p-toluenesulfonyl-2-amino-3-cyano-4-phenyl-5-benzoylpyrrole with the following structural formula as an example, the specific synthesis method is as follows:
向50mL圆底烧瓶中依次加入0.457g(1mmol)1-苯基-3-苯基-2-(4-甲基苯磺酰氨基)-3-溴丙酮-1、0.066g(1mmol)丙二腈、0.106g(1mmol)碳酸钠、5mL甲醇,在50℃下磁力搅拌反应8小时,然后加入25mL乙酸乙酯,用饱和食盐水洗三次(每次25mL),再用水洗涤三次(每次25mL),有机相以无水硫酸钠干燥过夜,过滤除去干燥剂,减压浓缩,粗产物进行硅胶柱色谱分离(以石油醚和乙酸乙酯体积比为5:1的混合液为洗脱剂),得到1-对甲苯磺酰基-2-氨基-3-氰基-4-苯基-5-苯甲酰基吡咯,其收率为89%,无水乙醇重结晶得淡黄色固体,熔点为188.8~190.2℃,结构表征数据如下:Add 0.457g (1mmol) 1-phenyl-3-phenyl-2-(4-methylbenzenesulfonylamino)-3-bromoacetone-1, 0.066g (1mmol) propylene glycol to a 50mL round bottom flask successively Nitrile, 0.106g (1mmol) sodium carbonate, 5mL methanol, magnetic stirring reaction at 50°C for 8 hours, then add 25mL ethyl acetate, wash with saturated brine three times (each 25mL), and then wash with water three times (each 25mL) , the organic phase was dried overnight with anhydrous sodium sulfate, filtered to remove the desiccant, concentrated under reduced pressure, and the crude product was subjected to silica gel column chromatography (with a mixture of petroleum ether and ethyl acetate volume ratio of 5:1 as eluent), 1-p-toluenesulfonyl-2-amino-3-cyano-4-phenyl-5-benzoylpyrrole was obtained in a yield of 89%, recrystallized from absolute ethanol to obtain a light yellow solid with a melting point of 188.8- 190.2°C, the structural characterization data are as follows:
1H NMR(400MHz,DMSO-d6)δ:7.48~7.41(m,7H),7.24(dd,J=14.3、4.0Hz,4H),7.12(m,5H),2.42(s,3H)。 1 H NMR (400 MHz, DMSO-d 6 ) δ: 7.48-7.41 (m, 7H), 7.24 (dd, J=14.3, 4.0 Hz, 4H), 7.12 (m, 5H), 2.42 (s, 3H).
13C NMR(100MHz,DMSO-d6)δ:190.2,150.7,146.5,136.2,133.4(2),131.3(2),130.2(2),129.3(2),128.9(2),128.5,128.2(2),128.0,127.0(2),126.9(2),124.9,114.5,72.6,21.2。 13 C NMR (100MHz, DMSO-d 6 ) δ: 190.2, 150.7, 146.5, 136.2, 133.4(2), 131.3(2), 130.2(2), 129.3(2), 128.9(2), 128.5, 128.2( 2), 128.0, 127.0(2), 126.9(2), 124.9, 114.5, 72.6, 21.2.
高分辨率质谱HRMS:计算值C25H19N3O3S([M+Na]+)464.1039,实测值464.1047。High resolution mass spectrum HRMS: Calcd. for C 25 H 19 N 3 O 3 S ([M+Na] + ) 464.1039, found 464.1047.
实施例2Example 2
以合成结构式如下的1-对甲苯磺酰基-2-氨基-3-氰基-4-(4-氯苯基)-5-苯甲酰基吡咯为例,具体合成方法如下:Taking the synthesis of 1-p-toluenesulfonyl-2-amino-3-cyano-4-(4-chlorophenyl)-5-benzoylpyrrole as an example, the specific synthesis method is as follows:
在实施例1中,所用的1-苯基-3-苯基-2-(4-甲基苯磺酰氨基)-3-溴丙酮-1用等摩尔的1-苯基-3-(4-氯苯基)-2-(4-甲基苯磺酰氨基)-3-溴丙酮-1替换,反应时间延长至14小时,其他步骤与实施例1相同,得到黄色固体1-对甲苯磺酰基-2-氨基-3-氰基-4-(4-氯苯基)-5-苯甲酰基吡咯,其收率为70%,熔点为198.8~199.9℃,结构表征数据如下:In Example 1, the 1-phenyl-3-phenyl-2-(4-methylbenzenesulfonylamino)-3-bromoacetone-1 was used with equimolar 1-phenyl-3-(4 -Chlorophenyl)-2-(4-methylbenzenesulfonylamino)-3-bromoacetone-1 was replaced, the reaction time was extended to 14 hours, and other steps were the same as in Example 1 to obtain yellow solid 1-p-toluenesulfonate Acyl-2-amino-3-cyano-4-(4-chlorophenyl)-5-benzoylpyrrole has a yield of 70%, a melting point of 198.8-199.9°C, and structural characterization data as follows:
1H NMR(400MHz,DMSO-d6)δ:7.47(m,7H),7.27(dd,J=14.2、6.5Hz,4H),7.19(d,J=8.4Hz,2H),7.11(d,J=8.4Hz,2H),2.42(s,3H)。 1 H NMR (400MHz, DMSO-d 6 ) δ: 7.47(m, 7H), 7.27(dd, J=14.2, 6.5Hz, 4H), 7.19(d, J=8.4Hz, 2H), 7.11(d, J=8.4Hz, 2H), 2.42(s, 3H).
13C NMR(100MHz,DMSO-d6)δ:190.0,150.8,146.7,136.2,133.4,133.2,133.0(2),130.3(2),129.0(2),128.3(2),128.3(2),127.2(2),126.9(2),126.7(2),125.30,114.4,72.7,21.2。 13 C NMR (100MHz, DMSO-d 6 ) δ: 190.0, 150.8, 146.7, 136.2, 133.4, 133.2, 133.0(2), 130.3(2), 129.0(2), 128.3(2), 128.3(2), 127.2(2), 126.9(2), 126.7(2), 125.30, 114.4, 72.7, 21.2.
高分辨率质谱HRMS:计算值C25H16ClN3O3S([M+Na]+)498.0650,实测值498.0652。High resolution mass spectrum HRMS: calculated for C 25 H 16 ClN 3 O 3 S ([M+Na] + ) 498.0650, found 498.0652.
实施例3Example 3
以合成结构式如下的1-对甲苯磺酰基-2-氨基-3-氰基-4-(4-溴苯基)-5-苯甲酰基吡咯为例,具体合成方法如下:Taking the synthesis of 1-p-toluenesulfonyl-2-amino-3-cyano-4-(4-bromophenyl)-5-benzoylpyrrole as an example with the following structural formula, the specific synthesis method is as follows:
在实施例1中,所用的1-苯基-3-苯基-2-(4-甲基苯磺酰氨基)-3-溴丙酮-1用等摩尔的1-苯基-3-(4-溴苯基)-2-(4-甲基苯磺酰氨基)-3-溴丙酮-1替换,反应时间延长至9小时,其他步骤与实施例1相同,得到黄色固体1-对甲苯磺酰基-2-氨基-3-氰基-4-(4-溴苯基)-5-苯甲酰基吡咯,其收率为84%,熔点为201.8~202.8℃,结构表征数据如下:In Example 1, the 1-phenyl-3-phenyl-2-(4-methylbenzenesulfonylamino)-3-bromoacetone-1 was used with equimolar 1-phenyl-3-(4 -Bromophenyl)-2-(4-methylbenzenesulfonylamino)-3-bromoacetone-1 was replaced, the reaction time was extended to 9 hours, and other steps were the same as in Example 1 to obtain yellow solid 1-p-toluenesulfonate Acyl-2-amino-3-cyano-4-(4-bromophenyl)-5-benzoylpyrrole has a yield of 84%, a melting point of 201.8-202.8°C, and structural characterization data as follows:
1H NMR(400MHz,DMSO-d6)δ:7.48(m,7H),7.37~7.22(m,6H),7.06(dd,J=8.2、2.4Hz,2H),2.40(s,3H)。 1 H NMR (400MHz, DMSO-d 6 ) δ: 7.48 (m, 7H), 7.37-7.22 (m, 6H), 7.06 (dd, J=8.2, 2.4Hz, 2H), 2.40 (s, 3H).
13C NMR(100MHz,DMSO-d6)δ:190.0,150.8,146.6,136.2,133.2,130.3(2),130.1(4),129.0(2),128.7(2),128.3(2),126.9(2),126.8,125.3,122.1(2),114.3,72.8,21.2。 13 C NMR (100MHz, DMSO-d 6 ) δ: 190.0, 150.8, 146.6, 136.2, 133.2, 130.3(2), 130.1(4), 129.0(2), 128.7(2), 128.3(2), 126.9( 2), 126.8, 125.3, 122.1(2), 114.3, 72.8, 21.2.
高分辨率质谱HRMS:计算值C25H16BrN3O3S([M+Na]+)542.0144,实测值542.0145。High resolution mass spectrum HRMS: Calcd. for C 25 H 16 BrN 3 O 3 S ([M+Na] + ) 542.0144, found 542.0145.
实施例4Example 4
以合成结构式如下的1-对甲苯磺酰基-2-氨基-3-氰基-4-(4-氟苯基)-5-(4-甲氧基苯甲酰基)吡咯为例,具体合成方法如下:Taking the following 1-p-toluenesulfonyl-2-amino-3-cyano-4-(4-fluorophenyl)-5-(4-methoxybenzoyl)pyrrole as an example, the specific synthetic method as follows:
在实施例1中,所用的1-苯基-3-苯基-2-(4-甲基苯磺酰氨基)-3-溴丙酮-1用等摩尔的1-(4-甲氧基苯基)-3-(4-氟苯基)-2-(4-甲基苯磺酰氨基)-3-溴丙酮-1替换,反应时间延长至18小时,其他步骤与实施例1相同,得到淡黄色固体1-对甲苯磺酰基-2-氨基-3-氰基-4-(4-氟苯基)-5-(4-甲氧基苯甲酰基)吡咯,其收率为69%,熔点为156.1~157.2℃,结构表征数据如下:In Example 1, the 1-phenyl-3-phenyl-2-(4-methylbenzenesulfonylamino)-3-bromoacetone-1 was used with equimolar 1-(4-methoxybenzene Base)-3-(4-fluorophenyl)-2-(4-methylbenzenesulfonylamino)-3-bromoacetone-1 replacement, the reaction time was extended to 18 hours, other steps were the same as in Example 1, and obtained Pale yellow solid 1-p-toluenesulfonyl-2-amino-3-cyano-4-(4-fluorophenyl)-5-(4-methoxybenzoyl)pyrrole in 69% yield, The melting point is 156.1-157.2°C, and the structural characterization data are as follows:
1H NMR(400MHz,DMSO-d6)δ:7.48(d,J=7.4Hz,6H),7.21(s,2H),7.14~7.09(m,2H),7.00(t,J=8.7Hz,2H),6.83(d,J=8.8Hz,2H),3.77(s,3H),2.42(s,3H)。 1 H NMR (400MHz, DMSO-d 6 ) δ: 7.48(d, J=7.4Hz, 6H), 7.21(s, 2H), 7.14~7.09(m, 2H), 7.00(t, J=8.7Hz, 2H), 6.83 (d, J = 8.8 Hz, 2H), 3.77 (s, 3H), 2.42 (s, 3H).
13C NMR(100MHz,DMSO-d6)δ:188.8,163.8,161.7,151.1,147.0,133.9,133.9(2),132.1(2),130.8(2),129.4(2),127.4(2),126.5,126.1,115.0,114.8,114.6,114.2(2),73.1,56.0,21.2。 13 C NMR (100MHz, DMSO-d 6 ) δ: 188.8, 163.8, 161.7, 151.1, 147.0, 133.9, 133.9(2), 132.1(2), 130.8(2), 129.4(2), 127.4(2), 126.5, 126.1, 115.0, 114.8, 114.6, 114.2(2), 73.1, 56.0, 21.2.
高分辨率质谱HRMS:计算值C26H20FN3O4S([M+Na]+)512.1051,实测值512.1048。High resolution mass spectrum HRMS: Calcd. for C 26 H 20 FN 3 O 4 S ([M+Na] + ) 512.1051, found 512.1048.
实施例5Example 5
以合成结构式如下的1-对甲苯磺酰基-2-氨基-3-氰基-4-苯基-5-(4-氯苯甲酰基)吡咯为例,具体合成方法如下:Taking the synthesis of 1-p-toluenesulfonyl-2-amino-3-cyano-4-phenyl-5-(4-chlorobenzoyl)pyrrole as an example, the specific synthesis method is as follows:
在实施例1中,所用的1-苯基-3-苯基-2-(4-甲基苯磺酰氨基)-3-溴丙酮-1用等摩尔的1-(4-氯苯基)-3-苯基-2-(4-甲基苯磺酰氨基)-3-溴丙酮-1换替,反应时间缩短至6小时,其他步骤与实施例1相同,得到黄色固体1-对甲苯磺酰基-2-氨基-3-氰基-4-苯基-5-(4-氯苯甲酰基)吡咯,其收率为91%,熔点为200.1~201.9℃,结构表征数据如下:In Example 1, 1-phenyl-3-phenyl-2-(4-methylbenzenesulfonylamino)-3-bromoacetone-1 was used with equimolar 1-(4-chlorophenyl) -3-phenyl-2-(4-methylbenzenesulfonylamino)-3-bromoacetone-1 was replaced, the reaction time was shortened to 6 hours, other steps were the same as in Example 1, and yellow solid 1-p-toluene was obtained Sulfonyl-2-amino-3-cyano-4-phenyl-5-(4-chlorobenzoyl)pyrrole has a yield of 91%, a melting point of 200.1-201.9°C, and structural characterization data as follows:
1H NMR(400MHz,DMSO-d6)δ:7.44(m,6H),7.29~7.17(m,5H),7.16~7.02(m,4H),2.41(s,3H)。 1 H NMR (400 MHz, DMSO-d 6 ) δ: 7.44 (m, 6H), 7.29-7.17 (m, 5H), 7.16-7.02 (m, 4H), 2.41 (s, 3H).
13C NMR(100MHz,DMSO-d6)δ:189.0,150.7,146.6,137.7,135.1,133.4,131.6(2),130.7(2),130.3(2),129.1(2),128.8,128.7,128.2(2),127.1(2),127.0(2),124.2,114.5,72.4,21.2。 13 C NMR (100MHz, DMSO-d 6 ) δ: 189.0, 150.7, 146.6, 137.7, 135.1, 133.4, 131.6(2), 130.7(2), 130.3(2), 129.1(2), 128.8, 128.7, 128.2 (2), 127.1(2), 127.0(2), 124.2, 114.5, 72.4, 21.2.
高分辨率质谱HRMS:计算值C25H16ClN3O3S([M+Na]+)498.0650,实测值498.0654。High resolution mass spectrum HRMS: calculated for C 25 H 16 ClN 3 O 3 S ([M+Na] + ) 498.0650, found 498.0654.
实施例6Example 6
以合成结构式如下的1-对甲苯磺酰基-2-氨基-3-氰基-4-(4-氟苯基)-5-苯甲酰基吡咯为例,具体合成方法如下:Taking the synthesis of 1-p-toluenesulfonyl-2-amino-3-cyano-4-(4-fluorophenyl)-5-benzoylpyrrole as an example with the following structural formula, the specific synthesis method is as follows:
在实施例1中,所用的1-苯基-3-苯基-2-(4-甲基苯磺酰氨基)-3-溴丙酮-1用等摩尔的1-苯基-3-(4-氟苯基)-2-(4-甲基苯磺酰氨基)-3-溴丙酮-1替换,反应时间延长至16小时,其他步骤与实施例1相同,得到黄色针状结晶1-对甲苯磺酰基-2-氨基-3-氰基-4-(4-氟苯基)-5-苯甲酰基吡咯,其收率为70%,熔点为189.9~190.2℃,结构表征数据如下:In Example 1, the 1-phenyl-3-phenyl-2-(4-methylbenzenesulfonylamino)-3-bromoacetone-1 was used with equimolar 1-phenyl-3-(4 -Fluorophenyl)-2-(4-methylbenzenesulfonylamino)-3-bromoacetone-1 was replaced, the reaction time was extended to 16 hours, other steps were the same as in Example 1, and yellow needle crystal 1-para Tosyl-2-amino-3-cyano-4-(4-fluorophenyl)-5-benzoylpyrrole has a yield of 70% and a melting point of 189.9-190.2°C. The structural characterization data are as follows:
1H NMR(400MHz,DMSO-d6)δ:7.46(m,7H),7.23(d,J=34.3Hz,4H),7.11(s,2H),6.98~6.87(m,2H),2.42(s,3H)。 1 H NMR (400MHz, DMSO-d 6 ) δ: 7.46(m, 7H), 7.23(d, J=34.3Hz, 4H), 7.11(s, 2H), 6.98~6.87(m, 2H), 2.42( s, 3H).
13C NMR(100MHz,DMSO-d6)δ:190.5,163.4,151.1,147.1,136.9,134.3,134.2,134.0,133.5,130.8(2),129.5(2),128.7(2),127.7,127.4(2),126.2,126.2,125.4,115.0,114.6,114.5,73.1,21.2。 13 C NMR (100MHz, DMSO-d 6 ) δ: 190.5, 163.4, 151.1, 147.1, 136.9, 134.3, 134.2, 134.0, 133.5, 130.8(2), 129.5(2), 128.7(2), 127.7, 127.4( 2), 126.2, 126.2, 125.4, 115.0, 114.6, 114.5, 73.1, 21.2.
高分辨率质谱HRMS:计算值C25H18FN3O3S([M+Na]+)482.0945,实测值482.0943。High resolution mass spectrum HRMS: calculated for C 25 H 18 FN 3 O 3 S ([M+Na] + ) 482.0945, found 482.0943.
实施例7Example 7
以合成结构式如下的1-对甲苯磺酰基-2-氨基-3-氰基-4-(4-氟苯基)-5-(4-氯苯甲酰基)吡咯为例,具体合成方法如下:Taking the synthesis of 1-p-toluenesulfonyl-2-amino-3-cyano-4-(4-fluorophenyl)-5-(4-chlorobenzoyl)pyrrole as an example, the specific synthesis method is as follows:
在实施例1中,所用的1-苯基-3-苯基-2-(4-甲基苯磺酰氨基)-3-溴丙酮-1用等摩尔的1-(4-氯苯基)-3-(4-氟苯基)-2-(4-甲基苯磺酰氨基)-3-溴丙酮-1替换,反应时间延长至10小时,其他步骤与实施例1相同,得到黄色针状结晶1-对甲苯磺酰基-2-氨基-3-氰基-4-(4-氟苯基)-5-(4-氯苯甲酰基)吡咯,其收率为76%,熔点为199.4~201.8℃,结构表征数据如下:In Example 1, 1-phenyl-3-phenyl-2-(4-methylbenzenesulfonylamino)-3-bromoacetone-1 was used with equimolar 1-(4-chlorophenyl) -3-(4-fluorophenyl)-2-(4-methylbenzenesulfonylamino)-3-bromoacetone-1 was replaced, the reaction time was extended to 10 hours, other steps were the same as in Example 1, and yellow needles were obtained 1-p-toluenesulfonyl-2-amino-3-cyano-4-(4-fluorophenyl)-5-(4-chlorobenzoyl)pyrrole as crystals, with a yield of 76% and a melting point of 199.4 ~201.8°C, the structural characterization data are as follows:
1H NMR(400MHz,DMSO-d6)δ:7.49~7.43(m,6H),7.29(d,J=8.4Hz,2H),7.21(s,2H),7.11(dd,J=8.7、5.5Hz,2H),6.96(t,J=8.8Hz,2H),2.40(s,3H)。 1 H NMR (400MHz, DMSO-d 6 ) δ: 7.49~7.43(m, 6H), 7.29(d, J=8.4Hz, 2H), 7.21(s, 2H), 7.11(dd, J=8.7, 5.5 Hz, 2H), 6.96 (t, J=8.8Hz, 2H), 2.40 (s, 3H).
13C NMR(100MHz,DMSO-d6)δ:188.9,163.4,161.0,150.6,146.6,137.7,135.2,134.0,134.0,133.4,130.8,130.3,128.2(2),127.9,126.9(2),125.5,125.5,124.4,114.5,114.2,21.2。 13 C NMR (100MHz, DMSO-d 6 ) δ: 188.9, 163.4, 161.0, 150.6, 146.6, 137.7, 135.2, 134.0, 134.0, 133.4, 130.8, 130.3, 128.2(2), 127.9, 126.9(2), 125.5 , 125.5, 124.4, 114.5, 114.2, 21.2.
高分辨率质谱HRMS:计算值C25H17FN3O3S([M+Na]+)516.0555,实测值516.0563。High resolution mass spectrum HRMS: Calcd. for C 25 H 17 FN 3 O 3 S ([M+Na] + ) 516.0555, found 516.0563.
实施例8Example 8
以合成结构式如下的1-对甲苯磺酰基-2-氨基-3-氰基-4-苯甲酰基-5-(4-甲氧基苯基)吡咯为例,具体合成方法如下:Taking the synthesis of 1-p-toluenesulfonyl-2-amino-3-cyano-4-benzoyl-5-(4-methoxyphenyl)pyrrole as an example, the specific synthesis method is as follows:
在实施例1中,所用的1-苯基-3-苯基-2-(4-甲基苯磺酰氨基)-3-溴丙酮-1用等摩尔的1-苯基-3-(4-甲氧基苯基)-3-(4-甲基苯磺酰氨基)-2-溴丙酮-1替换,反应时间延长至24小时,其他步骤与实施例1相同,得到黄色固体1-对甲苯磺酰基-2-氨基-3-氰基-4-苯甲酰基-5-(4-甲氧基苯基)吡咯,其收率为49%,熔点为196.8~198.8℃,结构表征数据如下:In Example 1, the 1-phenyl-3-phenyl-2-(4-methylbenzenesulfonylamino)-3-bromoacetone-1 was used with equimolar 1-phenyl-3-(4 -Methoxyphenyl)-3-(4-methylbenzenesulfonylamino)-2-bromoacetone-1 was replaced, the reaction time was extended to 24 hours, and other steps were the same as in Example 1 to obtain yellow solid 1-para Tosyl-2-amino-3-cyano-4-benzoyl-5-(4-methoxyphenyl)pyrrole has a yield of 49%, a melting point of 196.8-198.8°C, and structural characterization data as follows :
1H NMR(400MHz,DMSO-d6)δ:7.49~7.42(m,7H),7.26(t,J=7.8Hz,2H),7.15(s,2H),6.96(d,J=8.7Hz,2H),6.66(d,J=8.8Hz,2H),3.66(s,3H),2.41(s,3H)。 1 H NMR (400MHz, DMSO-d 6 ) δ: 7.49~7.42(m, 7H), 7.26(t, J=7.8Hz, 2H), 7.15(s, 2H), 6.96(d, J=8.7Hz, 2H), 6.66 (d, J = 8.8 Hz, 2H), 3.66 (s, 3H), 2.41 (s, 3H).
13C NMR(100MHz,DMSO-d6)δ:190.2,159.4,150.5,146.4,136.4,133.5,133.0,130.2(2),129.0(4),128.4,128.2,126.9(2),124.2(2),121.2,114.6,112.5(2),72.4,55.0,21.2. 13 C NMR (100MHz, DMSO-d 6 ) δ: 190.2, 159.4, 150.5, 146.4, 136.4, 133.5, 133.0, 130.2(2), 129.0(4), 128.4, 128.2, 126.9(2), 124.2(2) , 121.2, 114.6, 112.5(2), 72.4, 55.0, 21.2.
高分辨率质谱HRMS:计算值C26H21N3O4S([M+Na]+)494.1145,实测值494.1149。High resolution mass spectrum HRMS: Calcd. for C 26 H 21 N 3 O 4 S ([M+Na] + ) 494.1145, found 494.1149.
实施例9Example 9
以合成结构式如下的1-对甲苯磺酰基-2-氨基-3-氰基-4-苯甲酰基-5-(4-甲基苯基)吡咯为例,具体合成方法如下:Taking the synthesis of 1-p-toluenesulfonyl-2-amino-3-cyano-4-benzoyl-5-(4-methylphenyl)pyrrole as an example with the following structural formula, the specific synthesis method is as follows:
在实施例1中,所用的1-苯基-3-苯基-2-(4-甲基苯磺酰氨基)-3-溴丙酮-1用等摩尔的1-苯基-3-(4-甲基苯基)-3-(4-甲基苯磺酰氨基)-2-溴丙酮-1替换,其他步骤与实施例1相同,得到黄色针状结晶1-对甲苯磺酰基-2-氨基-3-氰基-4-苯甲酰基-5-(4-甲基苯基)吡咯,其收率为59%,熔点为196.2~197.8℃,结构表征数据如下:In Example 1, the 1-phenyl-3-phenyl-2-(4-methylbenzenesulfonylamino)-3-bromoacetone-1 was used with equimolar 1-phenyl-3-(4 -Methylphenyl)-3-(4-methylbenzenesulfonylamino)-2-bromoacetone-1 replacement, other steps are the same as in Example 1, to obtain yellow needle crystal 1-p-toluenesulfonyl-2- Amino-3-cyano-4-benzoyl-5-(4-methylphenyl)pyrrole has a yield of 59%, a melting point of 196.2-197.8°C, and structural characterization data as follows:
1H NMR(400MHz,DMSO-d6)δ:7.46(m,7H),7.27(s,2H),7.18(s,2H),6.94(s,4H),2.42(s,3H),2.19(s,3H)。 1 H NMR (400 MHz, DMSO-d 6 ) δ: 7.46 (m, 7H), 7.27 (s, 2H), 7.18 (s, 2H), 6.94 (s, 4H), 2.42 (s, 3H), 2.19 ( s, 3H).
13C NMR(100MHz,DMSO-d6)δ:190.7,151.1,146.9,138.5,136.8,134.0,133.6,131.7(2),130.7(2),129.5(2),128.8(2),128.6,128.2(2),127.4(2),126.9,125.1,115.0,73.1,21.7,21.3。 13 C NMR (100MHz, DMSO-d 6 ) δ: 190.7, 151.1, 146.9, 138.5, 136.8, 134.0, 133.6, 131.7(2), 130.7(2), 129.5(2), 128.8(2), 128.6, 128.2 (2), 127.4(2), 126.9, 125.1, 115.0, 73.1, 21.7, 21.3.
高分辨率质谱HRMS:计算值C26H21N3O3S([M+Na]+)478.1196,实测值478.1193。High resolution mass spectrum HRMS: Calculated for C 26 H 21 N 3 O 3 S ([M+Na] + ) 478.1196, found 478.1193.
实施例10Example 10
以合成结构式如下的1-对甲苯磺酰基-2-氨基-3-氰基-4-(4-氯苯甲酰基)-5-(4-甲氧基苯基)吡咯为例,具体合成方法如下:Taking the following 1-p-toluenesulfonyl-2-amino-3-cyano-4-(4-chlorobenzoyl)-5-(4-methoxyphenyl)pyrrole as an example, the specific synthetic method as follows:
在实施例1中,所用的1-苯基-3-苯基-2-(4-甲基苯磺酰氨基)-3-溴丙酮-1用等摩尔的1-(-氯苯基)-3-(4-甲氧基苯基)-3-(4-甲基苯磺酰氨基)-2-溴丙酮-1替换,反应时间延长至24小时,其他步骤与实施例1相同,得到黄色固体1-对甲苯磺酰基-2-氨基-3-氰基-4-(4-氯苯甲酰基)-5-(4-甲氧基苯基)吡咯,其收率为43%,熔点为206.2~207.5℃,结构表征数据如下:In Example 1, 1-phenyl-3-phenyl-2-(4-methylbenzenesulfonylamino)-3-bromoacetone-1 was used with equimolar 1-(-chlorophenyl)- 3-(4-methoxyphenyl)-3-(4-methylbenzenesulfonylamino)-2-bromoacetone-1 was replaced, the reaction time was extended to 24 hours, and other steps were the same as in Example 1 to obtain yellow Solid 1-p-toluenesulfonyl-2-amino-3-cyano-4-(4-chlorobenzoyl)-5-(4-methoxyphenyl)pyrrole in 43% yield, melting point 206.2~207.5℃, the structural characterization data are as follows:
1H NMR(400MHz,DMSO-d6)δ:7.47~7.39(m,6H),7.28(d,J=8.5Hz,2H),7.15(s,2H),6.94(d,J=8.7Hz,2H),6.65(d,J=8.8Hz,2H),3.68(s,3H),2.40(s,3H)。 1 H NMR (400MHz, DMSO-d 6 ) δ: 7.47~7.39(m, 6H), 7.28(d, J=8.5Hz, 2H), 7.15(s, 2H), 6.94(d, J=8.7Hz, 2H), 6.65 (d, J = 8.8 Hz, 2H), 3.68 (s, 3H), 2.40 (s, 3H).
13C NMR(100MHz,DMSO-d6)δ:189.1,159.6,150.4,146.5,137.4,135.3,133.5,133.2(2),130.7(2),130.2(2),129.3,128.2(2),126.9(2),123.7,121.0,114.7,112.6(2),72.2,55.1,21.2。 13 C NMR (100MHz, DMSO-d 6 ) δ: 189.1, 159.6, 150.4, 146.5, 137.4, 135.3, 133.5, 133.2(2), 130.7(2), 130.2(2), 129.3, 128.2(2), 126.9 (2), 123.7, 121.0, 114.7, 112.6(2), 72.2, 55.1, 21.2.
高分辨率质谱HRMS:计算值C26H20N3O4S([M+Na]+)528.0755,实测值528.0754。High resolution mass spectrum HRMS: Calcd. for C 26 H 20 N 3 O 4 S ([M+Na] + ) 528.0755, found 528.0754.
实施例11Example 11
以合成结构式如下的1-对甲苯磺酰基-2-氨基-3-氰基-4-(4-硝基苯甲酰基)-5-(4-甲氧基苯基)吡咯为例,具体合成方法如下:Taking the following 1-p-toluenesulfonyl-2-amino-3-cyano-4-(4-nitrobenzoyl)-5-(4-methoxyphenyl)pyrrole as an example, the specific synthesis Methods as below:
在实施例1中,所用的1-苯基-3-苯基-2-(4-甲基苯磺酰氨基)-3-溴丙酮-1用等摩尔的1-(4-硝基苯基)-3-(4-甲氧基苯基)-3-(4-甲基苯磺酰氨基)-2-溴丙酮-1替换,反应时间延长至24小时,其他步骤与实施例1相同,得到黄色固体1-对甲苯磺酰基-2-氨基-3-氰基-4-(4-硝基苯甲酰基)-5-(4-甲氧基苯基)吡咯,其收率为35%,熔点为199.1~200.4℃,结构表征数据如下:In Example 1, the 1-phenyl-3-phenyl-2-(4-methylbenzenesulfonylamino)-3-bromoacetone-1 was used with equimolar 1-(4-nitrophenyl )-3-(4-methoxyphenyl)-3-(4-methylbenzenesulfonylamino)-2-bromoacetone-1 was replaced, the reaction time was extended to 24 hours, and other steps were the same as in Example 1, 1-p-Toluenesulfonyl-2-amino-3-cyano-4-(4-nitrobenzoyl)-5-(4-methoxyphenyl)pyrrole was obtained as a yellow solid in 35% yield , the melting point is 199.1~200.4℃, and the structural characterization data are as follows:
1H NMR(600MHz,DMSO-d6)δ:7.93(d,J=6.8Hz,2H),7.58~7.37(m,6H),7.15(s,2H),6.90(d,J=6.8Hz,2H),6.56(d,J=6.3Hz,2H),3.60(s,3H),2.38(s,3H)。 1 H NMR (600MHz, DMSO-d 6 ) δ: 7.93(d, J=6.8Hz, 2H), 7.58~7.37(m, 6H), 7.15(s, 2H), 6.90(d, J=6.8Hz, 2H), 6.56 (d, J = 6.3 Hz, 2H), 3.60 (s, 3H), 2.38 (s, 3H).
13C NMR(100MHz,DMSO-d6)δ:189.4,160.3,151.0,149.1,147.1,143.0,134.2,134.1(2),131.8,130.8(2),130.4(2),127.5(2),123.8,123.3(2),121.1,115.2,113.0(2),72.6,55.6,21.2。 13 C NMR (100MHz, DMSO-d 6 ) δ: 189.4, 160.3, 151.0, 149.1, 147.1, 143.0, 134.2, 134.1(2), 131.8, 130.8(2), 130.4(2), 127.5(2), 123.8 , 123.3(2), 121.1, 115.2, 113.0(2), 72.6, 55.6, 21.2.
高分辨率质谱HRMS:计算值C26H20N4O6S([M+Na]+)539.0996,实测值539.0998。High resolution mass spectrum HRMS: Calcd. for C 26 H 20 N 4 O 6 S ([M+Na] + ) 539.0996, found 539.0998.
实施例12Example 12
以合成结构式如下的1-对甲苯磺酰基-2-氨基-3-氰基-4-(4-甲氧基苯甲酰基)-5-(4-甲氧基苯基)吡咯为例,具体合成方法如下:Taking 1-p-toluenesulfonyl-2-amino-3-cyano-4-(4-methoxybenzoyl)-5-(4-methoxyphenyl)pyrrole as an example with the following synthetic structural formula, the specific The synthesis method is as follows:
在实施例1中,所用的1-苯基-3-苯基-2-(4-甲基苯磺酰氨基)-3-溴丙酮-1用等摩尔的1-(4-甲氧基苯基)-3-(4-甲氧基苯基)-3-(4-甲基苯磺酰氨基)-2-溴丙酮-1替换,反应时间延长至24小时,其他步骤与实施例1相同,得到黄色固体1-对甲苯磺酰基-2-氨基-3-氰基-4-(4-甲氧基苯甲酰基)-5-(4-甲氧基苯基)吡咯,其收率为40%,熔点为188.9~190.2℃,结构表征数据如下:In Example 1, the 1-phenyl-3-phenyl-2-(4-methylbenzenesulfonylamino)-3-bromoacetone-1 was used with equimolar 1-(4-methoxybenzene Base)-3-(4-methoxyphenyl)-3-(4-methylbenzenesulfonylamino)-2-bromoacetone-1 replacement, the reaction time was extended to 24 hours, other steps were the same as in Example 1 , to obtain 1-p-toluenesulfonyl-2-amino-3-cyano-4-(4-methoxybenzoyl)-5-(4-methoxyphenyl)pyrrole as a yellow solid in a yield of 40%, the melting point is 188.9-190.2°C, and the structural characterization data are as follows:
1H NMR(400MHz,DMSO-d6)δ:7.51~7.42(m,6H),7.13(s,2H),6.97(d,J=6.7Hz,2H),6.76(dd,J=68.5、7.1Hz,4H),3.76(s,3H),3.68(s,3H),2.41(s,3H)。 1 H NMR (400MHz, DMSO-d 6 ) δ: 7.51~7.42 (m, 6H), 7.13 (s, 2H), 6.97 (d, J=6.7Hz, 2H), 6.76 (dd, J=68.5, 7.1 Hz, 4H), 3.76(s, 3H), 3.68(s, 3H), 2.41(s, 3H).
13C NMR(100MHz,DMSO-d6)δ:189.0,163.7,159.8,150.9,146.8,133.2(2),132.1(2),130.7(2),129.5(2),127.4,125.3(2),122.0,114.2,113.2(4),73.0,56.0,55.5,21.7。 13 C NMR (100MHz, DMSO-d 6 ) δ: 189.0, 163.7, 159.8, 150.9, 146.8, 133.2(2), 132.1(2), 130.7(2), 129.5(2), 127.4, 125.3(2), 122.0, 114.2, 113.2(4), 73.0, 56.0, 55.5, 21.7.
高分辨率质谱HRMS:计算值C27H23N3O5S([M+Na]+)524.1251,实测值524.1245。High resolution mass spectrum HRMS: Calcd. for C 27 H 23 N 3 O 5 S ([M+Na] + ) 524.1251, found 524.1245.
上述实施例1~12中,所用的Na2CO3也可用等摩尔的乙酸钠、K2CO3、KHCO3、K3PO4、NaOH、KOH、乙二胺或三乙胺替换,所用的甲醇也可用等体积的乙醇、丙醇、N,N-二甲基甲酰胺、乙腈、二甲亚砜替换,其他步骤与相应实施例相同。In the above-mentioned Examples 1-12, the Na2CO3 used can also be replaced by equimolar sodium acetate, K2CO3 , KHCO3 , K3PO4 , NaOH, KOH, ethylenediamine or triethylamine . Methanol can also be replaced by an equal volume of ethanol, propanol, N,N-dimethylformamide, acetonitrile, and dimethyl sulfoxide, and other steps are the same as in the corresponding examples.
Claims (6)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610395018.5A CN106008305B (en) | 2016-06-06 | 2016-06-06 | A kind of synthetic method of five substitutions 2- amino-pyrroles derivatives |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610395018.5A CN106008305B (en) | 2016-06-06 | 2016-06-06 | A kind of synthetic method of five substitutions 2- amino-pyrroles derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN106008305A CN106008305A (en) | 2016-10-12 |
| CN106008305B true CN106008305B (en) | 2018-05-08 |
Family
ID=57089608
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610395018.5A Expired - Fee Related CN106008305B (en) | 2016-06-06 | 2016-06-06 | A kind of synthetic method of five substitutions 2- amino-pyrroles derivatives |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106008305B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107382815B (en) * | 2017-08-07 | 2019-12-03 | 陕西师范大学 | A kind of five replace the synthetic method of 2- amino -2- pyrroline derivative |
| CN112266349B (en) * | 2020-11-17 | 2022-02-15 | 上海凌凯医药科技有限公司 | Method for preparing 2-amino-4-methyl-1-propyl-1H-pyrrole-3-carbonitrile |
| CN114950558B (en) * | 2021-02-22 | 2023-08-11 | 陕西师范大学 | Bipiperidine framework tetradentate nitrogen-containing manganese catalyst and method for catalyzing benzyl position selective oxidation of hydrocarbon molecule |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6346534B1 (en) * | 1998-09-23 | 2002-02-12 | Neurocrine Biosciences, Inc. | Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998043973A1 (en) * | 1997-03-27 | 1998-10-08 | Novartis Ag | Intermediate products and method for the production of pyrimidine derivatives |
-
2016
- 2016-06-06 CN CN201610395018.5A patent/CN106008305B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6346534B1 (en) * | 1998-09-23 | 2002-02-12 | Neurocrine Biosciences, Inc. | Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
Non-Patent Citations (4)
| Title |
|---|
| Design of a Versatile Multicomponent Reaction Leading to 2-amino-5-ketoaryl pyrroles;Kan W.et al.;《Chem Biol Drug Des》;20091206;第75卷;第277-283页 * |
| One-Pot Multicomponent Synthesis of Diversely Substituted 2-Aminopyrroles. A Short General Synthesis of Rigidins A,B, C, and D;Liliya V.F.et al.;《Organic Letters》;20110126;第13卷(第5期);第1118-1121页 * |
| Reaction of α-Azidoketones with Highly Stabilized Michael Acceptors: A New Synthesis of Densely Functionalized Pyrroles;Jose L.M.et al.;《Tetrahedron Letters》;19951231;第36卷(第30期);第5393-5396页 * |
| Synthesis, characterisation and bioactivity of polysubstituted 1-(4-(1H-pyrrol-1-yl)phenyl)- 1H-pyrrole derivatives;Abdel Z.A.et al.;《Journal of Chemical Research》;20120630;第328-332页 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN106008305A (en) | 2016-10-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Karpov et al. | Straightforward novel one-pot enaminone and pyrimidine syntheses by coupling-addition-cyclocondensation sequences | |
| CN101190899B (en) | A method for synthesizing 1,2-dihydroquinazolin-4(3H)-ketones | |
| CN106008305B (en) | A kind of synthetic method of five substitutions 2- amino-pyrroles derivatives | |
| CN107250102B (en) | Method for producing benzidine from azobenzene by ruthenium catalysis | |
| CN105732619B (en) | A kind of synthetic method of 5,6,7,8 tetrahydropyridines simultaneously [2,3 d] pyrimidines | |
| CN107235992B (en) | Indolinone spirotetrahydrothiophene compound and its salt, preparation method and application | |
| CN103922992B (en) | A kind of antitumour activity indolone derivatives, preparation method and use | |
| CN106831474B (en) | One kind-the α containing alpha-aromatic, β-diamino acid ester derivant and its synthetic method and application | |
| CN107382815B (en) | A kind of five replace the synthetic method of 2- amino -2- pyrroline derivative | |
| CN104016929B (en) | A kind of method for synthesizing quinazoline-4 (3H)-ketone | |
| CN108033913A (en) | A kind of pyrazoline quinoline derivant and its preparation method and application | |
| CN106946875A (en) | A kind of preparation method of the imidazole heterocyclic compounds of 3 oxygen substitutions of C | |
| CN108976241A (en) | A kind of synthetic method of chirality 1,4- dihydropyran simultaneously [2,3-c] pyrazole compound | |
| CN111662202A (en) | Synthetic method of alpha-ketoamide compound | |
| CN106467481B (en) | The synthetic method of indoles -3- aryl ketone derivatives | |
| CN105384698B (en) | Synthetic method for quinazolinone FPR2 formyl peptide receptor agonist | |
| CN106083649B (en) | A kind of synthetic method of the Cyclohexadiene derivatives of 3,5 diaryl, 2,6,6 tricyano, 1 imino group 2,4 | |
| CN116283707A (en) | Synthesis method of indole compound promoted by visible light | |
| KR101584731B1 (en) | A novel tubulin polymerization inhibitor, and the synthesizing method thereof | |
| CN114671868A (en) | A kind of pyridone-containing polysubstituted indolizine compound and its preparation method and application | |
| CN115677708A (en) | Preparation method of pyrroloquinoxaline | |
| CN107163062A (en) | A kind of sulphonyl lactone compound and preparation method thereof | |
| CN112939839B (en) | A kind of synthetic method of 2-aroyl pyrrole compounds | |
| CN106854191B (en) | Synthesis method of 3-methylene-2,3-dihydrofuran containing chiral quaternary carbon center at 2-position | |
| CN111875544B (en) | A kind of synthetic method of N-substituted hydantoin compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20180508 Termination date: 20210606 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |